NIVALIS THERAPEUTICS INC - COM (NVLS)

CUSIP: 65481J109

Q1 2017 13F Holders as of 31 Mar 2017

Type / Class
Equity / COM
Total 13F shares
8,286,462
Share change
-1,583,304
Total reported value
$24,195,000
Price per share
$2.92
Number of holders
27
Value change
-$3,073,520
Number of buys
14
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 65481J109?
CUSIP 65481J109 identifies NVLS - NIVALIS THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NIVALIS THERAPEUTICS INC - COM (NVLS) as of Q1 2017

As of 31 Mar 2017, NIVALIS THERAPEUTICS INC - COM (NVLS) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,286,462 shares. The largest 10 holders included DEERFIELD MANAGEMENT CO, BVF INC/IL, TIGER MANAGEMENT L.L.C., Rock Springs Capital Management LP, VANGUARD GROUP INC, Spark Investment Management LLC, PANAGORA ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 27 institutional shareholders reporting positions in this security for the Q1 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.